Our data suggest that exogenous IL-2 is unnecessary for the assessment of γδTc cytotoxicity against breast cancer cell lines (Figure 3) and indeed its propensity to drive activated T cells into apoptosis (33) further warrants its exclusion from such assays. The gene discussed is IL2; the disease is breast cancer.